Arbutus Biopharma Corp: Form DEF 14A, filed Dec 6, 2017
Filed with the SEC on Dec 6, 2017 and accepted by EDGAR at Dec 6, 2017, 14:54 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001628280-17-012143. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.